Logo Image
|Videos|December 4, 2020

Specialty Telemedicine: How it differs from traditional telemedicine

Jonathan Wiesen, MD, founder and chief medical officer of MediOrbis, discusses specialty telemedicine and its uses.

Jonathan Wiesen, MD, founder and chief medical officer of MediOrbis, discusses specialty telemedicine and its uses.

Related Content

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?
Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

View more